{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-11-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "SBL",
      "openfda": {
        "pma_number": [
          "P230016"
        ],
        "registration_number": [
          "2022180",
          "2916205",
          "3009189893"
        ],
        "fei_number": [
          "2022180",
          "2916205",
          "3009189893"
        ]
      },
      "review_panel": "PA",
      "medical_specialty": "HE",
      "device_name": "Immunohistochemistry Assay, Antibody, Melanoma-Associated Antigen A4",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Hematology",
      "device_class": "3",
      "definition": "Melanoma-associated antigen A4 (MAGE-A4) antibody is a qualitative immunohistochemical antibody, intended for use in the detection of MAGE-A4 protein expression in human clinical tissue specimens. The MAGE A4 antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs.",
      "regulation_number": "864.1860",
      "implant_flag": "N",
      "submission_type_id": "2"
    }
  ]
}